{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "[0040] FIG. 8A is a plot showing the relative infectivity in A549 cells pretreated with 13 additionally identified compounds.\n\n[0041] FIG. 8B shows the high-content images of A549 cells after immunostaining, in which the cells were pre- treated with Compound #1, Compound #7, Compound #9 or Compound #11 respectively, then infected with about 50 MOI of JEV.\n\n[0053] Berbamine has a structure of Formula (I)\n\nFormula (1)\n\n[0042] FIG. 9A shows the cytotoxicity of berbamine A549 cells, BHK-21 cells, Vero cells, Hela cells, and Huh cells.\n\n[0043] FIG. 9B illustrates the animal experiment, in which mice were injected with JEV, and then administered with PBS as the control group or berbamine as the treatment group.\n\n[0044] FIG. 9C shows the survival rate of mice after JEV challenge followed by treatment of berbamine for 15 days.\n\n[0045] FIG. 9D shows the body weight change of mice after JEV challenge followed by treatment of berbamine for days.\n\n[0046] FIG. 10 shows the high-content images of RD cells after immunostaining, in which the cells were pretreated with berbamine with the indicated doses, and then infected with 10 MOI of EV-71, as well as a plot of relative infectivity of EV-71 in the pretreated cells with ECso being about 17.3 uM.\n\n[0054] Analogues of berbamine generally share a core structure of Formula (Ib):\n\n[0047] FIG. 11 shows the high-content images of A549 cells after immunostaining, in which the cells were pre- treated with berbamine, and then infected with lentivirus encoding histone B-RFP; and the corresponding quantitative plot.\n\n(Ib)\n\nOR, : SS OR, RO A S N. aa \u516d r) Swe SS OO OR;\n\nDETAILED DESCRIPTION OF THE\n\n[0048] Unless otherwise defined, all technical terms used herein have the same meaning as commonly understood skilled in the art to which the invention belongs.", "type": "Document"}}